Literature DB >> 19356970

Diabetes preceding Parkinson's disease onset. A case-control study.

Marco D'Amelio1, Paolo Ragonese, Graziella Callari, Norma Di Benedetto, Barbara Palmeri, Valeria Terruso, Giuseppe Salemi, Giorgia Famoso, Paolo Aridon, Giovanni Savettieri.   

Abstract

OBJECTIVE: To assess the association between diabetes preceding Parkinson's disease (PD) and PD.
METHODS: PD individuals were matched to PD free individuals randomly selected from people in the same municipality as the cases. Occurrence of diabetes preceding PD onset among cases and controls was assessed through a structured questionnaire. Information regarding current and past medical treatment and other variables was also collected. We used univariate and multivariate logistic models to calculate crude and adjusted odds ratios (OR). Covariates are adjusted for included education, smoking habit, alcohol and coffee consumption.
RESULTS: 318 PD individuals (165 women, 153 men) and 318 matched controls were included in the study. PD patients had a mean age at interview of 66.7 years. Mean age at PD onset was 60.8 years and mean PD duration 5.9 years. We found an inverse association between PD and diabetes preceding PD onset in all groups stratified by gender, age at PD onset, body mass index (BMI), smoking habit, alcohol and coffee consumption. Multivariate analysis yielded the same findings after controlling for the variables (adjusted OR 0.4; 95% CI, 0.2-0.8).
CONCLUSIONS: Our findings provide additional support for a potential link between diabetes and PD.

Entities:  

Mesh:

Year:  2009        PMID: 19356970     DOI: 10.1016/j.parkreldis.2009.02.013

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  30 in total

Review 1.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

2.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

3.  Metabolic markers or conditions preceding Parkinson's disease: a case-control study.

Authors:  Rodolfo Savica; Brandon R Grossardt; J Eric Ahlskog; Walter A Rocca
Journal:  Mov Disord       Date:  2012-06-01       Impact factor: 10.338

Review 4.  Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.

Authors:  Sandeep Xxxx; Mir Hilal Ahmad; Linchi Rani; Amal Chandra Mondal
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

5.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

Authors:  Sarah M Rothman; Kathleen J Griffioen; Kenneth W Fishbein; Richard G Spencer; Sokratis Makrogiannis; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2013-10-22       Impact factor: 4.673

Review 6.  Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase.

Authors:  Medha Priyadarshini; Mohammad A Kamal; Nigel H Greig; Marcella Reale; Adel M Abuzenadah; Adeel G A Chaudhary; Ghazi A Damanhouri
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

7.  Diabetes and risk of Parkinson's disease.

Authors:  Qun Xu; Yikyung Park; Xuemei Huang; Albert Hollenbeck; Aaron Blair; Arthur Schatzkin; Honglei Chen
Journal:  Diabetes Care       Date:  2011-03-04       Impact factor: 19.112

8.  Diabetes and the risk of developing Parkinson's disease in Denmark.

Authors:  Eva Schernhammer; Johnni Hansen; Kathrine Rugbjerg; Lene Wermuth; Beate Ritz
Journal:  Diabetes Care       Date:  2011-03-16       Impact factor: 19.112

9.  Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line.

Authors:  Natasha Chandiramani; Xianhong Wang; Marta Margeta
Journal:  PLoS One       Date:  2011-01-04       Impact factor: 3.240

10.  Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

Authors:  Judith A Potashkin; Jose A Santiago; Bernard M Ravina; Arthur Watts; Alexey A Leontovich
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.